Shopping Cart
- Remove All
Your shopping cart is currently empty
Lampalizumab (RG 7417) is a humanized monoclonal antibody targeting Complement Factor D in the complement pathway, used in age-related macular degeneration (AMD) and cardiovascular disease research.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $263 | In Stock | |
| 5 mg | $795 | In Stock | |
| 10 mg | $1,260 | In Stock | |
| 25 mg | $1,870 | In Stock | |
| 50 mg | $2,520 | In Stock |
| Description | Lampalizumab (RG 7417) is a humanized monoclonal antibody targeting Complement Factor D in the complement pathway, used in age-related macular degeneration (AMD) and cardiovascular disease research. |
| In vivo | Lampalizumab achieved rapid equilibrium in eye tissue after intravitreal administration in cynomophagus monkeys. Its elimination is relatively slow in the eyes, τ1/2 in about 3 days, while the whole body is quickly eliminated, τ1/2 in 0.8 hours. [1] |
| Synonyms | TNX234, TNX 234, RG7417, RG 7417, Anti-CFD Recombinant Antibody |
| Molecular Weight | 46.96 (kDa) |
| Cas No. | 1278466-20-8 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.